Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285076932> ?p ?o ?g. }
Showing items 1 to 92 of
92
with 100 items per page.
- W4285076932 endingPage "5325" @default.
- W4285076932 startingPage "5317" @default.
- W4285076932 abstract "Background Proprotein convertase subtilisin/kexin type (PCSK9) inhibitor is a new drug class approved for treating dyslipidemias. Herein, we aimed to investigate the safety profiles of PCSK9 inhibitors (alirocumab and evolocumab) using the Food and Drug Administration Adverse Event Reporting System (FAERS). Methods We included adverse event (AE) reports regarding alirocumab and evolocumab submitted to the FAERs between 2015Q3 to 2021Q1. Disproportionality analyses, including reporting odds ratio (ROR), were performed to detect risk signals from the FAERs data to identify potential drug‐AE associations. A signal was considered when the lower limit of the 95% confidence interval of ROR exceeded 1 and ≥3 AEs were reported. The definition relied on system organ class and preferred terms established by the Medical Dictionary for Regulatory Activities. Results The FAERS database documented 31 475 reports regarding PCSK9 inhibitors (alirocumab and evolocumab) from July 1, 2015, to March 31, 2021. Although some differences were detected, alirocumab and evolocumab shared considerably similar safety profiles. The most significant RORs and most common reports were injection‐site reactions (eg, injection‐site pain, bruising, haemorrhage, erythema), muscle‐related AEs (eg, myalgia, back pain, arthralgia, muscle spasms), influenza‐like illness, pain and headache. Conclusion Data mining of the FAERs is useful for examining PCSK9 inhibitor‐induced AEs. Herein, our findings were largely consistent with clinical experience and could help clinicians improve the safety of PCSK9 inhibitors in clinical practice." @default.
- W4285076932 created "2022-07-13" @default.
- W4285076932 creator A5006996275 @default.
- W4285076932 creator A5008149388 @default.
- W4285076932 creator A5058247084 @default.
- W4285076932 creator A5073593046 @default.
- W4285076932 creator A5079873570 @default.
- W4285076932 date "2022-07-20" @default.
- W4285076932 modified "2023-09-25" @default.
- W4285076932 title "Adverse event profiles of PCSK9 inhibitors alirocumab and evolocumab: Data mining of the FDA adverse event reporting system" @default.
- W4285076932 cites W1520609538 @default.
- W4285076932 cites W1992858822 @default.
- W4285076932 cites W2001328643 @default.
- W4285076932 cites W2113514677 @default.
- W4285076932 cites W2138438666 @default.
- W4285076932 cites W2139585168 @default.
- W4285076932 cites W2170662336 @default.
- W4285076932 cites W2314193179 @default.
- W4285076932 cites W2405361272 @default.
- W4285076932 cites W2595226750 @default.
- W4285076932 cites W2596179513 @default.
- W4285076932 cites W2773258653 @default.
- W4285076932 cites W2802447912 @default.
- W4285076932 cites W2899997727 @default.
- W4285076932 cites W2953804067 @default.
- W4285076932 cites W2963950750 @default.
- W4285076932 cites W2982155199 @default.
- W4285076932 cites W2982221027 @default.
- W4285076932 cites W3016255169 @default.
- W4285076932 cites W3023156691 @default.
- W4285076932 cites W3128325240 @default.
- W4285076932 cites W4213436893 @default.
- W4285076932 doi "https://doi.org/10.1111/bcp.15460" @default.
- W4285076932 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35818959" @default.
- W4285076932 hasPublicationYear "2022" @default.
- W4285076932 type Work @default.
- W4285076932 citedByCount "6" @default.
- W4285076932 countsByYear W42850769322022 @default.
- W4285076932 countsByYear W42850769322023 @default.
- W4285076932 crossrefType "journal-article" @default.
- W4285076932 hasAuthorship W4285076932A5006996275 @default.
- W4285076932 hasAuthorship W4285076932A5008149388 @default.
- W4285076932 hasAuthorship W4285076932A5058247084 @default.
- W4285076932 hasAuthorship W4285076932A5073593046 @default.
- W4285076932 hasAuthorship W4285076932A5079873570 @default.
- W4285076932 hasConcept C126322002 @default.
- W4285076932 hasConcept C197934379 @default.
- W4285076932 hasConcept C2777105317 @default.
- W4285076932 hasConcept C2778114629 @default.
- W4285076932 hasConcept C2778163477 @default.
- W4285076932 hasConcept C2780072125 @default.
- W4285076932 hasConcept C2780745583 @default.
- W4285076932 hasConcept C2780902209 @default.
- W4285076932 hasConcept C2780948078 @default.
- W4285076932 hasConcept C43554185 @default.
- W4285076932 hasConcept C62746215 @default.
- W4285076932 hasConcept C71924100 @default.
- W4285076932 hasConcept C98274493 @default.
- W4285076932 hasConceptScore W4285076932C126322002 @default.
- W4285076932 hasConceptScore W4285076932C197934379 @default.
- W4285076932 hasConceptScore W4285076932C2777105317 @default.
- W4285076932 hasConceptScore W4285076932C2778114629 @default.
- W4285076932 hasConceptScore W4285076932C2778163477 @default.
- W4285076932 hasConceptScore W4285076932C2780072125 @default.
- W4285076932 hasConceptScore W4285076932C2780745583 @default.
- W4285076932 hasConceptScore W4285076932C2780902209 @default.
- W4285076932 hasConceptScore W4285076932C2780948078 @default.
- W4285076932 hasConceptScore W4285076932C43554185 @default.
- W4285076932 hasConceptScore W4285076932C62746215 @default.
- W4285076932 hasConceptScore W4285076932C71924100 @default.
- W4285076932 hasConceptScore W4285076932C98274493 @default.
- W4285076932 hasIssue "12" @default.
- W4285076932 hasLocation W42850769321 @default.
- W4285076932 hasLocation W42850769322 @default.
- W4285076932 hasOpenAccess W4285076932 @default.
- W4285076932 hasPrimaryLocation W42850769321 @default.
- W4285076932 hasRelatedWork W2105896644 @default.
- W4285076932 hasRelatedWork W2177476087 @default.
- W4285076932 hasRelatedWork W2534010974 @default.
- W4285076932 hasRelatedWork W2585426472 @default.
- W4285076932 hasRelatedWork W2620969414 @default.
- W4285076932 hasRelatedWork W2742143560 @default.
- W4285076932 hasRelatedWork W2897350816 @default.
- W4285076932 hasRelatedWork W4200003153 @default.
- W4285076932 hasRelatedWork W4285076932 @default.
- W4285076932 hasRelatedWork W4313490198 @default.
- W4285076932 hasVolume "88" @default.
- W4285076932 isParatext "false" @default.
- W4285076932 isRetracted "false" @default.
- W4285076932 workType "article" @default.